Nuclear factor-?B (NF-?B) represents a family of inducible transcription factors, that regulates a large array of genes involved in different processes of the immune and in ammatory responses. Deregulated NF-?B activation contributes to the pathogenic process of various diseases such as in ammation and cancer. NF-?B signaling in cancer cells is involved in cellular proliferation, angiogenesis, invasion, metastasis, development of drug resistance and antiapoptosis. Objective: To identify potent NF-?B and I?Ba inhibitors using molecular docking study. Methods: Proteins and ligands were prepared from Pymol and AutoDock vina and results were visualized by using Discovery studio visualizer. Results: Natural bioactive compounds such as Brevilin A, Tagitinin E, Japonicone G and Hiyodorilactone A were targeted on NF-?B and I?Ba. The docking score of the Brevilin A, Tagitinin E, Japonicone G and Hiyodorilactone A with NF-?B were -9.8Kcal/mol, -10.1Kcal/mol, -11.9Kcal/mol, and - 8.4Kcal/mol respectively. The docking score of the Brevilin A, Tagitinin E, Japonicone G and Hiyodorilactone A with I?Ba were 7.1Kcal/mol, -7.0Kcal/mol, -8.8Kcal/mol and -6.8Kcal/mol respectively. Control group (JSH-23 synthetic inhibitor) showed -6.5Kcal/mol and -5.5Kcal/mol with NF-?B and I?Ba respectively. Conclusions: The present study re ects that Brevilin A, Tagitinin E, Japonicone G and Hiyodorilactone A show promising results as a crucial drug target in NF-?B signaling cascade. However, to validate the inhibitory activity of these ligands further in-vitro analysis is suggested to develop novel anti-in ammatory/anti-cancer drugs.